CSL Seqirus Expands U.S. Influenza Vaccine Availability Ahead Of Flu Season
CANBERA (dpa-AFX) - Tuesday, CSL Seqirus, a business of CSL (CSL.AX), said it has expanded the availability of influenza vaccines in the U.S. following the successful completion of its 2026/27 manufacturing campaign.The company said most customer orders have already been shipped, with remaining del…